What is a weight-neutral diabetic medication? What do you do if the patient does

What is a weight-neutral diabetic medication? What do you do if the patient does not want an injection?
Expectations
Length: A minimum of 100 words, not including references
Citations: At least one high-level scholarly references in APA from within the last 5 years
Relate with the original post below
Question oneOne class of medications for type 2 diabetes has been shown to reduce hunger and calorie intake, hence aiding in weight loss. Medications in this category are typically referred to as GLP-1 agonists and an example is Exenatide (Ross & Douglas, 2019).Question twoGLP-1 receptor agonist is the suggested treatment. To begin, 5 mcg of the generic drug exenatide is taken subcutaneously twice daily, preferably before meals.Question threeHypersensitivity to the medicine, a previous diagnosis of pancreatitis, or family history of medullary thyroid cancer are all reasons to avoid GLP-1 receptor agonists. GLP-1 based drugs affect glycemic management by reducing postprandial glucagon and food intake and by delaying gastric emptying (Ross & Douglas, 2019). They also increase glucose-dependent insulin secretion. In the absence of medicines that produce hypoglycemia, these drugs do not typically cause hypoglycemia.Question fourHypothyroidism symptoms might vary widely across individuals. And they frequently mimic the signs of other diseases (Bekkering et al., 2019). This means that symptoms alone aren’t enough for a diagnosis of hypothyroidism. The results of blood tests are typically used for this purpose. As a first-line blood test for hypothyroidism, TSH levels are frequently examined. T-4 (a type of thyroid hormone) levels in the blood will also be checked if this one is abnormally high. Hypothyroidism is diagnosed if TSH is elevated and free T-4 is low. T-3, another thyroid hormone, may be evaluated in some situations. Low TSH levels along with elevated free T4 levels characterize hyperthyroidism (Bekkering et al., 2019).Question fiveLevothyroxine, a hormone replacement tablet, is commonly used to treat hypothyroidism, or an underactive thyroid. Levothyroxine is the generic name, and the recommended starting dose is 25-50 mcg taken orally once daily. Levothyroxine is an artificial analogue of thyroxine (T4), which the body metabolizes into triiodothyronine (T3) (Ross & Douglas, 2019). It is used to make up for the body’s lack of thyroid hormone. After determining the optimal dosage, patients typically undergo annual blood tests to track their hormone levels.When the patient’s thyroid is unable to produce enough of the thyroxine hormone, levothyroxine can be taken to restore normal levels (Idrees et al., 2020). Until the optimal levothyroxine dosage is determined, the patient will have routine blood tests. The levothyroxine dose may be started low and increased gradually based on the patient’s response. Some patients report improvement in symptoms shortly after starting treatment, while others may have to wait several months.Question sixHeart palpitations, tremors, loss of weight, sleeplessness, diarrhea, and an inability to tolerate heat are all possible adverse reactions (Ross & Douglas, 2019). There may be some unwanted consequences, but in most cases they do not warrant medical care. During treatment, the patient’s body may become accustomed to the medication and the symptoms will disappear.This patients should to take their medications first thing in the morning, preferably 30-60 minutes before eating anything. Within 4 hours of using levothyroxine, the patient should not take any calcium or iron supplements or certain antacids. Indicators of over medication include weariness, constipation, and dry skin, while indicators of under medication include rapid or irregular heartbeat and chest discomfort (Ross & Douglas, 2019). Thyroid hormone levels must be monitored and followed up on often so that the dosage can be adjusted as needed.References:Bekkering, G. E., Agoritsas, T., Lytvyn, L., Heen, A. F., Feller, M., Moutzouri, E., Abdulazeem, H., Aertgeerts, B., Beecher, D., & Brito, J. P. (2019). Thyroid hormones treatment for subclinical hypothyroidism: A clinical practice guideline. Bmj, 365. https://www.bmj.com/content/365/bmj.l2006.longIdrees, T., Palmer, S., Maciel, R. M. B., & Bianco, A. C. (2020). Liothyronine and desiccated thyroid extract in the treatment of hypothyroidism. Thyroid, 30(10), 1399–1413. https://doi.org/10.1089/thy.2020.0153Ross, D. S., & Douglas, S. (2019). Patient education: Hypothyroidism (underactive thyroid)(Beyond the Basics). Montefiore Medical Center and the Albert Einstein College of Medicine, USA. https://aqchealth.com/userfiles/file/Hypothyroidis…